MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma
出版年份 2015 全文链接
标题
MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma
作者
关键词
Cloning, Apoptosis, Microarrays, Cell cycle and cell division, MicroRNAs, MTT assay, Cancer treatment, Regulator genes
出版物
PLoS One
Volume 10, Issue 11, Pages e0143755
出版商
Public Library of Science (PLoS)
发表日期
2015-11-26
DOI
10.1371/journal.pone.0143755
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells
- (2015) Solange Tréhoux et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine
- (2015) Claudia Fiorini et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells
- (2015) Yehua Shen et al. TUMOR BIOLOGY
- MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer
- (2014) Guang-jun Zhang et al. BMC CANCER
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- microRNA-148a Is a Prognostic oncomiR That Targets MIG6 and BIM to Regulate EGFR and Apoptosis in Glioblastoma
- (2014) J. Kim et al. CANCER RESEARCH
- Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling
- (2014) Susann Weissmueller et al. CELL
- The MAPK-activated protein kinase 2 mediates gemcitabine sensitivity in pancreatic cancer cells
- (2014) Frederik Köpper et al. CELL CYCLE
- Id1-Induced IGF-II and Its Autocrine/Endocrine Promotion of Esophageal Cancer Progression and Chemoresistance--Implications for IGF-II and IGF-IR-Targeted Therapy
- (2014) B. Li et al. CLINICAL CANCER RESEARCH
- Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks
- (2014) Xiao Ling Li et al. FEBS LETTERS
- miR-99a/100 125b tricistrons regulate hematopoietic stem and progenitor cell homeostasis by shifting the balance between TGF and Wnt signaling
- (2014) S. Emmrich et al. GENES & DEVELOPMENT
- Transport properties of pancreatic cancer describe gemcitabine delivery and response
- (2014) Eugene J. Koay et al. JOURNAL OF CLINICAL INVESTIGATION
- A miRNA Signature of Chemoresistant Mesenchymal Phenotype Identifies Novel Molecular Targets Associated with Advanced Pancreatic Cancer
- (2014) Alakesh Bera et al. PLoS One
- Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer
- (2014) Allen S. Ho et al. Translational Oncology
- miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1
- (2013) Y Iwagami et al. BRITISH JOURNAL OF CANCER
- MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways
- (2013) N Wu et al. BRITISH JOURNAL OF CANCER
- Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors
- (2013) Andliena Tahiri et al. CARCINOGENESIS
- Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer
- (2013) S. Wang et al. Clinical & Translational Oncology
- Insulin-Like Growth Factor 1 Receptor Promotes the Growth and Chemoresistance of Pancreatic Cancer
- (2013) Xiaodong Tian et al. DIGESTIVE DISEASES AND SCIENCES
- Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial
- (2013) William Greenhalf et al. JNCI-Journal of the National Cancer Institute
- Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas
- (2013) Shuai Wang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells
- (2013) S Masciarelli et al. ONCOGENE
- Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer
- (2013) J Wang et al. ONCOGENE
- The Rescue of miR-148a Expression in Pancreatic Cancer: An Inappropriate Therapeutic Tool
- (2013) Yannick Delpu et al. PLoS One
- Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy
- (2012) En-hai Cui et al. ACTA PHARMACOLOGICA SINICA
- Levels of Gemcitabine Transport and Metabolism Proteins Predict Survival Times of Patients Treated With Gemcitabine for Pancreatic Adenocarcinoma
- (2012) Raphaël Maréchal et al. GASTROENTEROLOGY
- Mutant p53: one name, many proteins
- (2012) W. A. Freed-Pastor et al. GENES & DEVELOPMENT
- MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma
- (2012) Niamh Lynam-Lennon et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
- (2012) Hongjiang Wang et al. PLoS One
- Bcl-2 Upregulation Induced by miR-21 Via a Direct Interaction Is Associated with Apoptosis and Chemoresistance in MIA PaCa-2 Pancreatic Cancer Cells
- (2011) Jie Dong et al. ARCHIVES OF MEDICAL RESEARCH
- Genomic Loss of miR-486 Regulates Tumor Progression and the OLFM4 Antiapoptotic Factor in Gastric Cancer
- (2011) H.-K. Oh et al. CLINICAL CANCER RESEARCH
- Epigenetic markers for chemosensitivity and chemoresistance in pancreatic cancer-A review
- (2011) Sameer Dhayat et al. INTERNATIONAL JOURNAL OF CANCER
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- miR-195, miR-455-3p and miR-10a∗ are implicated in acquired temozolomide resistance in glioblastoma multiforme cells
- (2010) Kenta Ujifuku et al. CANCER LETTERS
- MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
- (2010) Elisa Giovannetti et al. CANCER RESEARCH
- Challenges of drug resistance in the management of pancreatic cancer
- (2010) Rizwan Sheikh et al. Expert Review of Anticancer Therapy
- Mutant p53-induced Up-regulation of Mitogen-activated Protein Kinase Kinase 3 Contributes to Gain of Function
- (2010) Aymone Gurtner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
- (2010) Ming Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Survival Prediction for Pancreatic Cancer Patients Receiving Gemcitabine Treatment
- (2010) Junichi Matsubara et al. MOLECULAR & CELLULAR PROTEOMICS
- Phenotype and Genotype of Pancreatic Cancer Cell Lines
- (2010) Emily L. Deer et al. PANCREAS
- miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes
- (2010) Xu-Bao Shi et al. PROSTATE
- microRNA-21 Negatively Regulates Cdc25A and Cell Cycle Progression in Colon Cancer Cells
- (2009) P. Wang et al. CANCER RESEARCH
- MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation
- (2009) K-H Lee et al. ONCOGENE
- MicroRNA Expression Profiles in Serous Ovarian Carcinoma
- (2008) E. J. Nam et al. CLINICAL CANCER RESEARCH
- IGF-1 Mediates PTEN Suppression and Enhances Cell Invasion and Proliferation via Activation of the IGF-1/PI3K/Akt Signaling Pathway in Pancreatic Cancer Cells
- (2008) Jiachi Ma et al. JOURNAL OF SURGICAL RESEARCH
- Prolonged Versus Standard Gemcitabine Infusion: Translation of Molecular Pharmacology to New Treatment Strategy
- (2008) S. A. Veltkamp et al. ONCOLOGIST
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started